The trading price of BioAtla Inc (NASDAQ:BCAB) closed lower on Monday, April 01, closing at $3.39, -1.45% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $4.07 and a 52-week low of $1.24. Over the past month, the stock has gained 25.56% in value.
BioAtla Inc, whose market valuation is $162.04 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.79 per share this quarter, however they have predicted annual earnings per share of -$2.76 for 2023 and -$1.93 for 2024. It means analysts are expecting annual earnings per share growth of -0.70% this year and 30.10% next year.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of BioAtla Inc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest BCAB has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 50% Buy.
A quick review shows that BCAB’s price is currently 25.79% off the SMA20 and 35.85% off the SMA50. The RSI metric on the 14-day chart is currently showing 67.97, and weekly volatility stands at 14.74%. When measured over the past 30 days, the indicator reaches 9.54%. BioAtla Inc (NASDAQ:BCAB)’s beta value is currently sitting at 1.06, while the Average True Range indicator is currently displaying 0.30.
To see how BioAtla Inc stock has been performing in comparison to its peers in the industry, here are the numbers: BCAB stock’s performance was -1.45% in the latest trading, and 35.06% in the past year.
An evaluation of the daily trading volume of BioAtla Inc (NASDAQ:BCAB) indicates that the 3-month average is 457.33K. However, this figure has increased over the past 10 days to an average of 0.66 million.
Currently, records show that 48.08 million of the company’s shares remain outstanding. The insiders hold 19.41% of outstanding shares, whereas institutions hold 54.97%. The stats also highlight that short interest as of Mar 15, 2024, stood at 5.13 million shares, resulting in a short ratio of 14.48 at that time. From this, we can conclude that short interest is 10.70% of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 5.04 million. However, since the stock’s price has seen 37.80% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
